This protocol presents a method to evaluate reactive oxygen species (ROS)-mediated apoptosis induced by natural compounds in non-small cell lung cancer (NSCLC) cells.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Research Article
* These authors contributed equally
This protocol presents a method to evaluate reactive oxygen species (ROS)-mediated apoptosis induced by natural compounds in non-small cell lung cancer (NSCLC) cells.
This study explores the anticancer potential of Pileostegia tomentella, with a particular focus on its ability to induce classical apoptosis in H1299 non-small cell lung cancer (NSCLC) cells through reactive oxygen species (ROS)-mediated pathways. Using a bioactivity-guided isolation approach, two active compounds, umbelliferone (UMB) and epi-Vogeloside, were identified as the major cytotoxic constituents. Both compounds exhibited significant inhibitory effects on cell viability and effectively triggered apoptotic cell death in H1299 cells. Mechanistic investigations demonstrated that treatment with UMB and epi-Vogeloside led to a marked increase in intracellular ROS levels, implicating oxidative stress as a key mediator. Western blot analysis revealed increased levels of cleaved caspase-3 and decreased expression of the anti-apoptotic protein Bcl-2, indicating activation of the intrinsic mitochondrial apoptotic pathway. Additionally, transcriptomic profiling showed widespread alterations in gene expression, further supporting disruption of cellular homeostasis. These results suggest that Pileostegia tomentella and its active constituents hold promise as potential therapeutic agents for lung cancer.
Cancer presents a formidable global public health challenge, characterized by a substantial annual mortality rate. Non-small cell lung cancer (NSCLC) is the principal global driver of cancer-related fatalities, constituting approximately 85% of lung cancer incidences1. Carcinogenesis, an inherently complex interplay of molecular and cellular processes, is critically influenced by disruptions in reactive oxygen species (ROS) homeostasis. ROS, which include unstable oxidants such as superoxide anions, hydroxyl radicals, and hydrogen peroxide, are byproducts of normal cellular metabolism and execute essential functions in signaling, proliferation,....
Access restricted. Please log in or start a trial to view this content.
The reagents and equipment used in this study are listed in the Table of Materials.
1. Chemical composition of Pileostegia tomentella and NSCLC target prediction
The chemical constituents of Pileostegia tomentella were analyzed using high-performance liquid chromatography combined with linear ion trap-Orbitrap mass spectrometry (HPLC-LTQ/MS). Extracts were dissolved in appropriate solvents and filtered before injection. Chromatographic separation was achieved using a reversed-phase column under a gradient elution program tailored for the compound classes. Mass spe....
Access restricted. Please log in or start a trial to view this content.
Screening of key components of Pileostegia tomentella against lung cancer
An overview of the experimental design is presented in Figure 1. HPLC-LTQ/Orbitrap MS was employed to characterize seven principal bioactive constituents present in Pileostegia tomentella (Table 3). Subsequently, an in silico target prediction was conducted on these compounds using the SwissTargetPrediction database
Access restricted. Please log in or start a trial to view this content.
Non-small cell lung cancer (NSCLC) remains a pressing global health concern, characterized by its aggressive biology, rapid clinical progression, and high metastatic potential, frequently resulting in poor patient outcomes12. Although standard interventions, such as surgical resection, radiotherapy, and chemotherapy, offer therapeutic benefit in early-stage disease, their effectiveness diminishes in advanced stages due to the emergence of drug resistance and the burden of systemic toxicity. The un.......
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest to declare.
This work was supported by the High-level Key Discipline Construction Project of Traditional Chinese Medicine - Ethnic Minority Pharmacy (Zhuang Pharmacy) from the State Administration of Traditional Chinese Medicine (No. zyyzdxk-2023165); the Talent Cultivation Program "Youth Project" of Guangxi International Zhuang Medical Hospital (No. 2022001); the Multidisciplinary Cross-Innovation Team Project in Chinese Medicine of Guangxi (No. GZKJ2309); the High-Level Talent Cultivation Innovation Team Program of Guangxi University of Traditional Chinese Medicine (No. 2022A008); the Key Research and Development Project of the Guangxi Science and Technology Department ....
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Annexin V–PE / 7-AAD Apoptosis Detection Kit | BD Biosciences | 556547 | Flow cytometry-based apoptosis detection |
| Antibody: BAX | Abcam | ab32503 | Western blot for pro-apoptotic protein |
| Antibody: Bcl-2 | Abcam | ab182858 | Western blot/immunofluorescence |
| Antibody: Cleaved Caspase-3 | Abcam | ab32042 | Western blot / IF |
| Antibody: GAPDH | Abcam | ab8245 | Internal control in Western blot |
| Antibody: PARP1 | Abcam | ab32064 | Western blot for apoptosis marker |
| Antibody: Tubulin | Abcam | ab78078 | Internal control in Western blot |
| ChemDraw | PerkinElmer Informatics | CCG821391 | Structure drawing of small molecules |
| Chemiluminescence Imaging System | Tanon Science & Technology | Tanon 5200 | For visualizing protein bands |
| Cytoscape | Cytoscape.org | https://cytoscape.org | Network construction and analysis |
| DAPI Nuclear Stain | Sigma | D9542 | Blue nuclear counterstain for IF |
| DAVID | NIH | https://david.ncifcrf.gov | Functional annotation and KEGG pathway enrichment |
| DMSO | Sigma | MFCD00002089 | Used to dissolve formazan crystals |
| Ethanol (for extraction) | Sigma | MFCD00003568 | Ultrasonic-assisted extraction solvent |
| Ethyl Acetate | Sigma | MFCD00009171 | Used for bioactive fractionation |
| FITC-conjugated Secondary Antibody | Abcam | ab6785 | Used in immunofluorescence |
| Flow Cytometer | Thermo Scientific | A29001 | Used for apoptosis and ROS detection |
| Fluorescence Microscope | Olympus Corporation | BX53F | For imaging immunofluorescence slides |
| Freeze Dryer | Labconco Corporation | 7670520 | For sample lyophilization and preservation |
| GeneCards | Weizmann Institute | https://www.genecards.org | Gene database for disease relevance |
| HPLC-LTQ-Orbitrap Mass Spectrometry | Thermo Scientific | IQLAAEGAAVFACZMAIK | Compound identification by MS |
| Illumina NovaSeq Sequencing Platform | Illumina Inc. | 20012850 | Used for RNA-seq |
| LDH Cytotoxicity Assay Kit | Beyotime | C0016 | For measuring LDH release as cytotoxicity indicator |
| Microplate Reader | Thermo Scientific | VL0000D0 | For absorbance measurements in MTT and LDH assays |
| MTT Cell Viability Assay Kit | Beyotime | C0009S | Used for MTT assay to assess cell viability |
| qPCR Machine | Thermo Scientific | 4485701 | For gene expression analysis |
| R software | R Foundation | https://www.r-project.org | Statistical computing and pathway plotting |
| Reverse Transcription Kit (RT Kit) | Vazyme | MR201 | For cDNA synthesis |
| RNA-seq Library Prep Kit | Illumina Inc. | 20020594 | Library preparation for sequencing |
| SwissTargetPrediction | Swiss Institute | http://www.swisstargetprediction.ch | Compound-target prediction tool |
| SYBR Green qPCR Mix | Vazyme | Q311-02 | For quantitative PCR |
| TRIzol Reagent (RNA extraction) | Sigma | T3934 | For total RNA extraction |
| Ultrasonic Cleaner | Branson | M1800-CPXH | For ultrasonic-assisted extraction |
| Western Blot Apparatus | Thermo Scientific | A56727 | Gel electrophoresis and protein transfer |
Access restricted. Please log in or start a trial to view this content.